Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Nabel

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Molecular Medicine (Cambridge, Mass.)|May 1, 1995
The MD PhD physician scientist--endangered species or the next generation?G J Nabel
Nature Medicine|April 15, 1999
Surviving Ebola virus infectionG J Nabel
Transactions of the American Clinical and Climatological Association|June 21, 2001
The Gordon Wilson Lecture: viruses and human diseaseG J Nabel
Nature|June 23, 1988
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factorK Leung, G J Nabel
Cytokine|May 1, 1994
Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sitesL Zhang, G J Nabel
Nature Medicine|April 1, 1996
Calories lost--another mediator of cancer cachexia?G J Nabel, C Grunfeld
Molecular and Cellular Biology|October 7, 1997
A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcriptionZ Li, G J Nabel
Biochimica Et Biophysica Acta|November 21, 1998
Keystone symposia on: molecular and cellular biology of gene therapy and synthetic non-viral gene delivery systems, Keystone, CO, USA, January 19-25, 1998G J Nabel, P Hobart
Current Opinion in Immunology|August 11, 2001
Vaccines for the prevention of HIV-1 diseaseJ R Mascola, G J Nabel
Trends in Biotechnology|May 1, 1993
Direct gene transfer for immunotherapy and immunizationG J Nabel, P L Felgner
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Molecular Medicine (Cambridge, Mass.)|May 1, 1995
The MD PhD physician scientist--endangered species or the next generation?G J Nabel
Nature Medicine|April 15, 1999
Surviving Ebola virus infectionG J Nabel
Transactions of the American Clinical and Climatological Association|June 21, 2001
The Gordon Wilson Lecture: viruses and human diseaseG J Nabel
Nature|June 23, 1988
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factorK Leung, G J Nabel
Cytokine|May 1, 1994
Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sitesL Zhang, G J Nabel
Nature Medicine|April 1, 1996
Calories lost--another mediator of cancer cachexia?G J Nabel, C Grunfeld
Molecular and Cellular Biology|October 7, 1997
A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcriptionZ Li, G J Nabel
Biochimica Et Biophysica Acta|November 21, 1998
Keystone symposia on: molecular and cellular biology of gene therapy and synthetic non-viral gene delivery systems, Keystone, CO, USA, January 19-25, 1998G J Nabel, P Hobart
Current Opinion in Immunology|August 11, 2001
Vaccines for the prevention of HIV-1 diseaseJ R Mascola, G J Nabel
Trends in Biotechnology|May 1, 1993
Direct gene transfer for immunotherapy and immunizationG J Nabel, P L Felgner
Pageof 18